Charterhouse sells Italian pharma company to CVC
The deal is understood to be in the range of €650 to €700 million and is slated to close in mid-2016.
The deal is understood to be in the range of €650 to €700 million and is slated to close in mid-2016.
Copyright PEI Media
Not for publication, email or dissemination